Nagaoka Red-Cross Hospital

Nagaoka-shi 940-2085

1 studies enrolling now · 2 studies all time

What they study most

Asthma, End Stage Kidney Disease

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication — Completed